Lingming Kong - Concepedia

Author

Lingming Kong

China Medical University ORCID

Also Known As

Kong, Lingming, Lingming Kong

Publications

701

Citations

H-Index

Concepts

All Affiliations

China Medical University First Hospital of China Medical University Wenzhou Medical University LMU Klinikum Ludwig-Maximilians-Universität München

About

Lingming Kong is an author at China Medical University specializing in tumor biology, cancer cell biology, and cancer biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	13
2	Cell Biology	1	1	13
3	Pathology	1	1	13
4	Cancer Cell Biology	1	1	13
5	Cell Signaling	1	1	13

Lingming Kong

Publications

611

Citations

H-Index

Page 1

	Year	Citations
Sitagliptin activates the p62–Keap1–Nrf2 signalling pathway to alleviate oxidative stress and excessive autophagy in severe acute pancreatitis-related acute lung injury Lingming Kong, Jie Deng, Xiang Zhou, Cell Death and Disease	2021	227
A hypoxia-related signature for clinically predicting diagnosis, prognosis and immune microenvironment of hepatocellular carcinoma patients Baohui Zhang, Bufu Tang, Jianyao Gao, Journal of Translational Medicine	2020	141
<p>The miR-1224-5p/ELF3 Axis Regulates Malignant Behaviors of Pancreatic Cancer via PI3K/AKT/Notch Signaling Pathways</p> Lingming Kong, Peng Liu, Mingjun Zheng, OncoTargets and Therapy	2020	46
A Prognostic Prediction Model Developed Based on Four CpG Sites and Weighted Correlation Network Analysis Identified DNAJB1 as a Novel Biomarker for Pancreatic Cancer Lingming Kong, Peng Liu, Fei Xiang, Frontiers in Oncology	2020	39
Differential secretome of pancreatic cancer cells in serum-containing conditioned medium reveals CCT8 as a new biomarker of pancreatic cancer invasion and metastasis Peng Liu, Lingming Kong, Haoyi Jin, Cancer Cell International	2019	31
Multi-Omics Analysis Based on Integrated Genomics, Epigenomics and Transcriptomics in Pancreatic Cancer Lingming Kong, Peng Liu, Mingjun Zheng, Epigenomics	2020	30
Identification of dissociation factors in pancreatic Cancer using a mass spectrometry-based proteomic approach Peng Liu, Lingming Kong, Keke Liang, BMC Cancer	2020	21
Identification of prognosis-related molecular subgroups based on DNA methylation in pancreatic cancer Xiaoli Yin, Lingming Kong, Peng Liu Clinical Epigenetics	2021	21
Identification of Novel Metabolism-Associated Subtypes for Pancreatic Cancer to Establish an Eighteen-Gene Risk Prediction Model Yang Gao, Enchong Zhang, Fei Xiang, Frontiers in Cell and Developmental Biology	2021	16
BUB1 Promotes Gemcitabine Resistance in Pancreatic Cancer Cells by Inhibiting Ferroptosis Wei‐Ming Wang, Xiang Zhou, Lingming Kong, Cancers	2024	14

Page 1